Bio Protocol vs TrueFi — how do they compare? Bio Protocol trades at Rp432.99 (market cap Rp983,55M, Rp163,9M 24h volume), while TrueFi trades at Rp43.12 (market cap Rp99,36M, Rp187,33M 24h volume). The key difference: Bio Protocol is far larger — about 9.9× TrueFi's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 1,4B / 1,5B TRU (99%) for TrueFi. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and TrueFi for 23 Days on average.
| BIO | TRU | |
|---|---|---|
Market Cap | Rp983,55M | Rp99,36M |
Volume (24h) | Rp163,9M | Rp187,33M |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 1,4B / 1,5B TRU (99%) |
Typical Hold Time | 18 Days | 23 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
TrueFi (TRU) shows limited market activity with a modest market cap of Rp99.36M and high circulation rate of 99%. The token has a relatively short average hold time of 23 days, suggesting active trading but potentially limited long-term conviction. Trading volumes appear constrained given the small market capitalization, with the token approaching its maximum supply limit of 1.5M TRU.
Overall outlook remains cautious due to minimal trading activity and liquidity concerns. Key opportunities include potential protocol utility if adoption increases, while major risks center around low liquidity, high volatility in thin markets, and limited ecosystem development. Investors should monitor for any protocol updates or exchange listings that could improve market dynamics.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →TrueFi is a protocol designed to create interest-generating pools that offer high annual percentage rates (APRs) for liquidity providers. It utilizes TrustTokens (TRU) for utility and rewards, incentivizing participants to maintain stable and competitive APRs.
Read more on TRU →